History of allergy to study drug components
History of allergy to study treatments or any of its components of the study arm that participant is enrolling
Patients with a history of allergy to the study drug components are excluded
Any history of allergy to the study drug components
History of allergy to study drug components
History of allergy to study drug components
History of allergy or intolerance to study drug components or polysorbate-80-containing infusions
History of allergy or hypersensitivity to study drug components
History of allergy to study drug components.
Any history of allergy to the study drug components
Known allergy to the study drugs or any of its components
Any history of allergy to the study drug components
History of allergy or intolerance (unacceptable adverse event) to study drugs components.
History of allergy to study drug components
History of allergy to study drug components
History of allergy to study drug components
History of allergy or adverse drug reaction to study components
History of allergy to study drug components
History of allergy to components of nivolumab or DS-8273A, or known allergy to other antibody therapies
History of sensitivity to any of the study medications, or components thereof or a history of drug or other allergy that, in the opinion of the investigator or Medical Monitor, contraindicates their participation.
History of allergy to study drug components
No contraindication to receiving radiotherapy and no known allergy to components of fresolimumab
History of allergy to study treatments or any of its components of the study arm that participant is enrolling
History of allergy to study drug components
History of allergy or hypersensitivity to nivolumab components
History of allergy to study drug components
Known allergy to any of the treatment components
Known allergy/hypersensitivity to drug or components
History of allergy or hypersensitivity to nivolumab drug components.
History of allergy or hypersensitivity to any of the study drugs or study drug components
Any history of allergy to the study drug components
History of allergy to study drug components.
Local or severe allergy to any components of the drug regimen.
Patient must not have a known allergy to any of the treatment components
Subject has a history of allergy or hypersensitivity to study drug components;
Have known allergy or hypersensitivity to any components of study treatment.
History of allergy to components of ipilimumab or panobinostat, or known allergy to other antibody therapies
Subject has a known allergy to ART-123 or any components of the drug product.
Allergies and Adverse Drug Reaction: History of allergy to study drug components
History of allergy to study drug components
History of allergy or intolerance (unacceptable adverse event) to study drugs components
Known allergy to any of the vaccine or adjuvant components, including eggs
Known allergy or adverse drug reaction to nivolumab, or a history of allergy to study drug components
Known allergy to any of the treatment components
The patient has known allergy to any of the treatment components
History of allergy to study drug components
History of allergy to nivolumab components
Known allergy to paclitaxel or any of its components
The patient has a known allergy/history of hypersensitivity reaction to any of the treatment components.
Allergy / history of hypersensitivity reaction to any of the treatment components
History of allergy to study drug components
History of known allergy to components of the study supplements
Known allergy to any of the treatment components.
Known allergy to any of the components of ATIR101 (e.g., dimethyl sulfoxide)
Known allergy to any of the components of ATIR101 (e.g., dimethyl sulfoxide)
Allergy to yeast or any of the components of Gardasil
History of allergy to any of the components of OTL38, including folic acid
History of allergy to any of the components of OTL38, including folic acid